Author:
Pennell Page B.,Ogaily Mohammed S.,Macdonald Robert L.
Abstract
Article abstract-A 53-year-old woman began taking felbamate for uncontrolled complex partial seizures. Four months later, she developed fatigue and ecchymotic skin lesions. Laboratory studies revealed very severe aplastic anemia. There have been an additional nine reported cases of aplastic anemia in the setting of felbamate treatment. The association between felbamate and aplastic anemia has resulted in a joint recommendation by the US Food and Drug Administration and the manufacturer of felbamate, Carter-Wallace, Inc., for the immediate withdrawal of patients from treatment with felbamate.NEUROLOGY 1995;45: 456-460
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference25 articles.
1. Sofia RD, Kramer L, Perhach JL, Rosenberg A. Felbamate. In: Pisani F, Perucca E, Avanzini G, Richens A, eds. New antiepileptic drugs. Amsterdam: Elsevier Science, 1991:103-108.
2. Workshop summary
3. Rho JM, Donevan SD, Rogawski MA. Effects of the dicarbamates felbamate and meprobamate on GABA-activated Cl - currents in cultured rat hippocampal neurons (abstract). Neurology 1994;44 (suppl 2):A237.
4. Motor dyscontrol in narcolepsy: Rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献